The hemagglutinin-esterases (HEs) are a family of viral envelope glycoproteins that mediate reversible attachment to O-acetylated sialic acids by acting both as lectins and as receptor-destroying enzymes (RDEs). Related HEs occur in influenza C, toro-, and coronaviruses, apparently as a result of relatively recent lateral gene transfer events. Here, we report the crystal structure of a coronavirus (CoV) HE in complex with its receptor. We show that CoV HE arose from an influenza C-like HE fusion protein (HEF). In the process, HE was transformed from a trimer into a dimer, whereas remnants of the fusion domain were adapted to establish novel monomer-monomer contacts. Whereas the structural design of the RDE-acetylesterase domain remained unaltered, the HE receptor-binding domain underwent remodeling to such extent that the ligand is now bound in opposite orientation. This is surprising, because the architecture of the HEF site was preserved in influenza A HA over a much larger evolutionary distance, a switch in receptor specificity and extensive antigenic variation notwithstanding. Apparently, HA and HEF are under more stringent selective constraints than HE, limiting their exploration of alternative binding-site topologies. We attribute the plasticity of the CoV HE receptor-binding site to evolutionary flexibility conferred by functional redundancy between HE and its companion spike protein S. Our findings offer unique insights into the structural and functional consequences of independent protein evolution after interviral gene exchange and open potential avenues to broad-spectrum antiviral drug design. sialic acid ͉ x-ray crystallography ͉ glycoprotein ͉ lectin ͉ nidovirus
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any different respiratory and enteric viruses initiate infection by binding to sialic acids. These nine-carbon amino sugars are common terminal residues of glycoconjugates and occur in a wide variety, which arises from differential modification of the parental molecule, 5-N-acetyl neuraminic acid (Neu5Ac), and from differences in glycosidic linkage (1) . Although viruses may attain host and cell specificity by being selective for particular sialic acid subtypes (1) (2) (3) (4) , even these receptors may still occur abundantly on off-target host cells (including the infected cell), on viral progeny, and on soluble and insoluble molecules in the extracellular environment. To prevent irreversible binding to ''decoy receptors'' and consequent loss of infectivity, orthomyxo-, paramyxo-, and coronaviruses encode virion-associated receptor-destroying enzymes (RDEs) (5-7). In turn, RDEs make prime targets for antiviral intervention, as exemplified by the influenza A virus neuraminidase (8) (9) (10) .
The coronaviruses are a group of enveloped (ϩ)strand RNA viruses that comprises several important pathogens of human clinical and veterinary importance, including severe acute respiratory syndrome (SARS)-coronavirus, human respiratory coronavirus (HCoV) OC43 and its proposed zoonotic ancestor (11) , bovine coronavirus (BCoV). HCoV-OC43 and BCoV use 9-O-acetylated sialic acids as receptor and correspondingly possess sialate-9-O-acetylesterases as RDE (12, 13) . Enzymatic activity is associated with the hemagglutinin-esterase (HE), a homodimeric class I membrane protein (for a review, see ref. 7) . Although among coronaviruses, HE is exclusive to members of phylogenetic subgroup 2a (7) , closely related proteins do occur in toroviruses (14) (15) (16) and in orthomyxoviruses of mammals (17) and fish (18) . Best studied is the influenza C virus HE fusion protein (HEF), a homotrimeric multifunctional spike protein that mediates virion attachment, receptor destruction, and membrane fusion (19) (20) (21) (22) .
The presence of homologous HE genes in the genomes of viruses from three distinct taxa is generally ascribed to RNA recombination and would have required two lateral gene transfer events at the minimum (7, 14, 23) . The source of the HE module and the direction of gene flow remain to be established, however (7) . Moreover, the influenza, toro-, and coronavirus HEs followed independent evolutionary trajectories, the functional and structural consequences of which are poorly understood. Unlike HEF, CoV HEs lack membrane fusion activity and, in the virion, they are accessory to the spike protein S, a receptor-binding fusion protein. Furthermore, although CoV HEs do bind to sialic acid, their role in virion attachment is subject to debate (7). Reportedly, CoV HEs serve primarily as RDE (24) , but this view is at variance with observations that esterase-deficient HE promotes viral spread in vivo (25) . Intriguingly, there is no obvious sequence homology between the HEF receptor-binding site and corresponding regions in HE, raising the question of whether CoV HEs possess a separate receptor-binding site or mediate sialic acid-binding and catalysis through a single site in the esterase pocket (7) .
To further our understanding of the function and evolution of coronavirus HEs, we expressed BCoV HE and solved its structure, free and in complex with its receptor.
active site Ser 40 -to-Ala substitution) as Fc-fusion proteins by transiently transfecting N-acetylglucosaminyltransferase-deficient HEK293S cells with expression plasmids encoding the respective molecules. Soluble CoV HE was purified by protein A-affinity chromatography of the Fc chimeras followed by on-the-bead thrombin digestion. The proteins were tested in a series of assays to confirm that biological functions had been retained also as an indication for proper folding. Indeed, in cleavage assays with a synthetic di-O-acetylated Sia (5-N-acetyl-4,9-di-O-acetylneuraminic acid ␣-methylglycoside, ␣Neu4,5,9Ac 3 2Me) as substrate, HE-Fc displayed sialate-9-O-acetylesterase activity (Fig. 1A) . In addition, HE-Fc, but not its esterase-deficient derivative HE 0 -Fc, specifically destroyed BCoV receptors on rat erythrocytes and on Madin-Darby bovine kidney (MDBK) cells ( Fig. 1 B and C) . Moreover, HE-Fc and HE 0 -Fc retained lectin activity as demonstrated by hemagglutination assay (Figs. 1C and 4E ) and by Sia-specific immunofluorescence staining of tissue culture cells (Fig. 1D) .
Structure Determination and Overall Structure. Crystals of free HE and of a complex of HE 0 with ␣Neu4,5,9Ac 3 2Me diffracted to 2.1 and 1.8 Å resolution, respectively. The structures were solved by molecular replacement by using influenza C HEF residues 35-410 as search model (for detailed crystallographic statistics, see Table 1 ).
The data reveal that the CoV HE monomer is composed of three modules, each with an equivalent in influenza C HEF subunit 1 (HEF1): a receptor-binding domain (R), an acetylesterase domain (E), and a membrane-proximal domain (MP; Fig.  2 A-C) . There is no equivalent of HEF subunit 2 (HEF2), which in HEF comprises the bulk of the fusion domain (F) (Fig. 2 B and  C) . Bound to the R domain is a well defined ligand molecule [supporting information (SI) Fig. S1 ] providing first and direct evidence for the presence of a genuine receptor-binding site. This observation unambiguously defines BCoV HE as a receptor-binding protein per se.
In the virion, CoV HE forms dimers that are disulphide-linked through Cys 385 near the C-terminal membrane anchor (7) . This bond, although present in HE crystals (Fig. S2) , was not visible in electron density maps because of disorder of residues 377-388. The biological dimer could, however, be identified uniquely from the proximity of C termini and size of interaction surface. It consists of identical molecules, related by twofold crystallographic symmetry, with an interface comprised of two major protein contact regions (CRs). CR1, associated with 952 Å 2 buried solvent-accessible surface, involves a continuous eightstranded ␤-sheet bridging the two R domains (Fig. 2D ). CR2 buries 1,182 Å 2 solvent-accessible surface and involves MP.
Origin and Evolution of CoV HE. The structure of MP provides a decisive clue to the origin of CoV HE. As shown in Fig. 3 , MP is strikingly similar to the F1/F2 globular region of HEF1 (22) and the FЈ subdomain in the influenza A virus HA (26) . In the native metastable forms of HEF and HA, these subdomains pack against a heptad-repeat loop that, as a prelude to membrane fusion, refolds into an ␣-helix at endosomal pH (26) . HEF and HA are evolutionarily related but diverged long ago; their fusion domains are similar in structure, as are their R domains, but overall sequence identity has dwindled to only 12% (22) . In contrast, HEF1 and CoV HE share 30% identity, indicative of a more recent split-off (7, 23) . The presence in HE of an element that already must have been part of a fusion protein ancestral to HA and HEF (22) thus indicates that CoV HE originates from an HEF-like fusion protein and strongly argues against evolutionary models in which orthomyxo-and coronaviruses independently acquired an HE module solely comprised of R and E (7). In the simplest scenario (23), a group 2a CoV progenitor obtained through recombination the 5Ј-end of an HEF gene, including the coding sequence for the fusion peptide that came to serve as transmembrane domain (Fig. 2C) . Without the HEF2 helical subdomain to direct trimerization, fortuitous interactions between transmembrane and/or F2 segments might have caused the HE protein to assemble into dimers instead; of note, the face of MP involved in dimer formation is equivalent to that of HEF segment F2 contacting the heptad repeat loop (Fig. 3) . A four-stranded ␤-sheet in the R domain that remains unpaired in HEF and HA trimers (22) may have been remodeled subsequently to create a second, membrane-distal intermonomer contact to increase dimer stability (Fig. 2D) . (Fig. 4A) . HE crystals soaked with 9-Oacetylated sialic acid did not contain this substrate in the enzymatic pocket. Instead, the oxyanion hole was occupied by an acetate ion, i.e., one of the catalytic products. The HEF and HE E domains do differ in size and structure of an extended surface loop (residues 47-54) that shields the catalytic pocket and that may prevent antibodies from accessing the functionally important esterase site (Fig. 4A ). This loop is highly variable even among coronavirus HEs (7), tentatively identifying it as a site of antigenic variation.
A Receptor-Binding Site in CoV HE. The R domain mediates receptor recognition (Fig. 1D) . Although its core, an eight-stranded ''Swiss roll,'' is structurally well conserved and closely resembles that of HEF and HA (Fig. S3) , its receptor-binding region is unique. This region is shaped by five variable loops, four grafted on the conserved core and one extending from the E domain. Differences between HE and HEF in loop size and conformation result in dramatically different binding sites that engage 9-Oacetylated sialic acid in nearly opposite orientations. Compared with the HEF-receptor complex, the receptor analogue bound to HE is rotated by 147°and shifted by 4 Å (Figs. 2D and 4B) . Conversely, HEF and HA are similar with respect to receptor orientation and binding site topology (22) (Figs. 4B and Fig. S3 ). In HE, a ␤-hairpin, replacing an ␣-helix in HEF and HA interacts with the receptor through hydrogen bonds from main chain atoms of Leu 212 and Asn 214 to the 5-N-acetyl-and carboxylate groups, respectively, and from the side chain of Ser 213 to O-8 (Fig. 4C) . The ␣-2-O-methyl group of the receptor analogue points into the solvent, of relevance, because at this position, the natural ligand would be linked to the penultimate residue of the sugar chain. The 5-N-acetyl group fits into a pocket, its methyl interacting with a hydrophobic patch formed mainly by Phe 211 (Fig. 4D) . The 9-O-acetyl methyl of the receptor analogue docks into an adjacent hydrophobic pocket, formed by Tyr 184 , Phe 211 , Leu 266 , and Leu 267 (Fig. 4 C and D) , with the latter two residues in a loop stabilized by a potassium ion coordinated by Asp 220 , Ser 221 , Gln 222 , Ser 263 , Glu 265 , Leu 267 , and one water (Fig. S4) . Given that the 9-O-acetyl moiety is a prerequisite for receptor binding and serves as a switch for virion attachment and release, this hydrophobic pocket must be key to ligand recognition. Indeed, Ala substitution of Phe 211 or of Leu 266 and Leu 267 in tandem abrogated receptor binding, whereas substitution of Tyr 184 decreased affinity significantly (Fig. 4E) .
Plasticity of the CoV HE Receptor-Binding Site. HEF also binds 9-O-acetylated sialic acid by contacting the 5-N-acetyl group through a hydrophobic patch and by burying the 9-O-acetyl in a nonpolar pocket (22) . Therefore, despite the considerable differences in receptor-binding site architecture, HEF and HE use similar strategies to discriminate functional receptors from non-O-acetylated sialic acids. It is, however, surprising that the HE receptor-binding site has changed to this extent at all. Over a much larger evolutionary distance, the architecture of the HEF receptor-binding site has been preserved in HA, despite differences in receptor specificity (Neu5,9Ac 2 vs. ␣2,3-or ␣2,6-linked Neu5Ac, respectively) and throughout antigenic variation (22, 26, 28) (Fig. 4B) . Unlike HA and HEF, however, CoV HE acts in concert with another receptor-binding protein, S, a fusion protein essential for entry, and whereas HE-mediated virion attachment may be advantageous (25) , it is not vital (16, 25, 29) . We propose that redundancy in function between S and HE (24) afforded CoVs leeway to explore HE-binding site topologies and even to shift in coreceptor usage from 9-O-to 4-O-acetylated sialic acids in one branch of murine coronaviruses (16, (30) (31) (32) . The plasticity of the CoV HE receptor-binding site contrasts with the strict conservation of the E domain and the esterase catalytic site. From a pragmatic point of view, this may potentially allow the development of broad-spectrum antivirals targeting both orthomyxo-and coronavirus sialate-Oacetylesterases.
Materials and Methods

Construction of Expression Plasmids.
A synthetic codon-optimized sequence for the HE ectodomain of BCoV strain Mebus (amino acid residues 19 -388) was cloned in a derivative of expression plasmid S1-Ig (33) . The resulting construct, pCD5-BCoVHE-T-Fc, encodes a chimeric HE protein provided with an Nterminal CD5 signal peptide and at its C terminus, separated by a thrombin cleavage site, the Fc domain of human IgG1. To allow expression of an enzymatically inactive HE-Fc chimera (HE 0 -Fc), we generated a derivative of pCD5-BCoVHE-T-Fc in which the codon for the esterase catalytic residue Ser 40 was substituted by Ala by site directed mutagenesis using the QuikChange XL II kit (Stratagene). Ala substitutions of key residues in the HE receptor-binding site were made likewise. (34) were transiently transfected with the expression plasmids using polyethyleneimine. At 18 h after transfection, the transfection mixture was replaced by 293 SFM II expression medium (Invitrogen), supplemented with sodium bicarbonate (3.7 g/liter), glucose (2.0 g/liter), Primatone RL-UF (3.0 g/liter), penicillin (100 units/ml), streptomycin (100 g/ ml), glutaMAX (Gibco), and 1.5% DMSO. Tissue culture supernatants were harvested 5-6 days after transfection, and HE-Fc and HE 0 -Fc were purified by protein A-affinity chromatography. For crystallography, the HE and HE 0 ectodomains were cleaved off by on-the-bead thrombin digestion, concentrated to 10 -15 mg/ml, and dialyzed against crystallization buffer (Tris⅐HCl, pH 8.2; 50 mM NaCl).
Protein Expression and Purification. HEK293S cells lacking N-acetylglucosaminyl-transferase I (GnTI) activity
Biological and Biochemical Characterization of HE-Fc Chimeras. Molecular weights of the proteins were determined by SDS/PAGE (under reducing and nonreducing conditions) and by gel filtration chromatography. O-acetylesterase activity was routinely measured by pNPA assay (19) . Enzymatic de-O-acetylation of ␣Neu4,5,9Ac32Me was analyzed by GC-MS (16, 35) . To assess esterase activity of the expression products toward cell-bound 9-O-acetylated sialic acids, MDBK cell monolayers in 16-mm diameter wells were treated with 20 g/ml HE-Fc or HE 0 -Fc in PBS for 2 h at 37°C and subsequently infected with BCoV strain Mebus. Monolayers, mock-treated or treated with Vibrio cholerea neuraminidase (NA; 0.6 units/ml), were included as controls. Infected cells were visualized by staining using an in situ acetylesterase assay (36) . Receptor-destroying activity toward 9-O-acetylated sialic acids on rat erythrocytes was assessed by incubating the cells with 20 g/ml HE-Fc in PBS for 2.5 h at 37°C, before hemagglutination assay with twofold serial dilutions of BCoV. In situ detection of 9-O-acetylated sialic acids in cultured cells was demonstrated by performing a standard indirect immunofluorescence assay. Briefly, monolayers of polarized MDBK cells, grown on glass coverslips, were fixed with 2% paraformaldehyde and successively incubated with Ϸ25 g/ml HE 0 -Fc in PBS, 0.05% Tween20 and with FITC-conjugated antihuman IgG1 (Nordic, 1:100) as secondary antibody. The samples were mounted on glass slides in FluorSave (Calbiochem) and examined by confocal fluorescence microscopy (Leica TCS SP2). grown with the hanging-drop vapor diffusion method set up by hand with 0.8 l of reservoir solution and 0. (16) , HE 0 was used to prevent substrate degradation during soaking. Crystals obtained from 0.1 M KH 2PO4, 10% (wt/vol) PEG 3350 cracked during ligand soaking and the flashfreezing procedure. Therefore, we used for substrate-soaking crystals of the mutant grown from 0.04 M KH 2PO4, 16% (wt/vol) PEG 8000, 20% (wt/vol) glycerol, which did not require addition of cryoprotectant. Soaking was performed by adding 2 l of reservoir solution with 10 mM Neu4,5,9Ac32Me directly into the margin of the drop with crystals, resulting in a final substrate concentration of Ϸ7 mM. Crystals were flash-frozen after 5-10 min.
Diffraction data of native and ligand-soaked crystals of BCoV HE were collected at European Synchrotron Radiation Facility station ID14-3 and ID 23-1, respectively. Diffraction data were processed by using XDS (37) and scaled using SCALA from the CCP4 suite (38) . Molecular replacement was performed by using PHASER with Influenza C HEF residues 35-410 as template [Protein Data Bank (PDB) ID code 1FLC]. Density modification was carried out by using RESOLVE (PHENIX package) (39) and CNS (40) . Approximately 280 residues were built automatically by ARP/WARP (41); the remaining residues were built manually with Coot (42) . Refinement was carried out by using REFMAC (43) ; water molecules were added by using ARP/WARP. Molecular graphics were generated with PYMOL (http://pymol.sourceforge.net).
The structure of HE 0 in complex with Neu4,5,9Ac32Me was solved by molecular replacement by using the wild-type HE structure as template. The structure was refined as described for wild-type HE. The library file for refinement of the ligand in REFMAC was made by adding chemical and geometric descriptions of the 4-and 9-O-acetyl groups to that of sialic acid (SIA) in the monomer library of the CCP4 suite by using the program SKETCHER (CCP4 Suite).
